Open AccessCytisine for Smoking Cessation
Author(s) -
JeanFrançois Etter
Publication year - 2006
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.166.15.1553
Subject(s) - cytisine , anabasine , placebo , medicine , smoking cessation , odds ratio , confidence interval , randomized controlled trial , varenicline , pharmacology , traditional medicine , nicotinic agonist , nicotine , alternative medicine , receptor , pathology
Cytisine is an agonist of nicotinic receptors; in particular, it binds strongly with alpha(4)beta(2) nicotinic receptors. Cytisine has been used to treat tobacco dependence for 40 years in Eastern Europe. The objective of this study was to review the literature on the effect of cytisine on smoking cessation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom